Literature DB >> 11508265

Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children.

K Sadeharju1, M Lönnrot, T Kimpimäki, K Savola, S Erkkilä, T Kalliokoski, P Savolainen, P Koskela, J Ilonen, O Simell, M Knip, H Hyöty.   

Abstract

AIMS/HYPOTHESIS: We evaluated the role of enterovirus infections in the pathogenesis of Type I (insulin-dependent) diabetes mellitus by monitoring enterovirus antibody levels in prediabetic children who turned positive for diabetes-associated autoantibodies in a prospective birth cohort study.
METHODS: Serial serum samples taken during prospective observation starting at birth were analysed for IgG and IgA class antibodies against enterovirus antigens including purified coxsackievirus B4, echovirus 11, poliovirus 1 and a synthetic enterovirus peptide antigen using enzyme immunoassay. Maternal samples taken at the end of the third month of pregnancy were also studied. Analyses were done from 21 childen who developed autoantibodies and from 104 autoantibody-negative control children who were matched for the time of birth, gender and HLA susceptibility alleles. For comparison, adenovirus antibodies were also analysed from all samples collected.
RESULTS: IgG class enterovirus antibody levels were high in maternal samples and in cord blood in both case and control children. After birth the IgG levels decreased reaching a nadir at the age of 6 months. No IgA class antibodies were detected at birth but started to emerge postnatally. Antibody levels did not differ between the autoantibody positive and the control children during the first 6 months of life. From 6 months to 24 months of age, the autoantibody positive children had higher IgG and IgA levels against coxsackievirus B4, echovirus 11 and the synthetic enterovirus peptide antigens than control children but poliovirus 1 and adenovirus antibodies were closely similar in the two groups. The difference between children with autoantibodies and control children was predominantly seen among boys and among those with the HLA-DQB1*0302/x genotype. CONCLUSIONS/
INTERPRETATION: Our data show that children who seroconverted for diabetes-associated auto-antibodies develop stronger humoral immune responses to coxsackievirus B4, echovirus 11 and a synthetic enterovirus peptide antigen than children who remained negative for autoantibodies. Poliovirus antibodies induced by uniform vaccinations did not differ between the prediabetic and control children suggesting that the regulation of antibody responses to enteroviruses is not disturbed. Accordingly, the results imply a stronger enterovirus exposure in prediabetic children supporting the role of enteroviruses in the pathogenesis of Type I diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508265     DOI: 10.1007/s001250100560

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

Review 1.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Viruses and Type 1 diabetes: a dynamic labile equilibrium.

Authors:  Darius A Schneider; Matthias G von Herrath
Journal:  Diabetes Manag (Lond)       Date:  2013-05

Review 4.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies.

Authors:  L C Stene; M Rewers
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 5.  Enteroviruses in the pathogenesis of type 1 diabetes.

Authors:  Sisko Tauriainen; Sami Oikarinen; Maarit Oikarinen; Heikki Hyöty
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

6.  Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation.

Authors:  H Viskari; J Ludvigsson; R Uibo; L Salur; D Marciulionyte; R Hermann; G Soltesz; M Füchtenbusch; A-G Ziegler; A Kondrashova; A Romanov; B Kaplan; Z Laron; P Koskela; T Vesikari; H Huhtala; M Knip; H Hyöty
Journal:  Diabetologia       Date:  2005-05-19       Impact factor: 10.122

7.  Diagnosis of enterovirus infection by genus-specific PCR and enzyme-linked immunosorbent assays.

Authors:  Maria E Craig; Peter Robertson; Neville J Howard; Martin Silink; William D Rawlinson
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16.

Authors:  E Cabrera-Rode; L Sarmiento; C Tiberti; G Molina; J Barrios; D Hernández; O Díaz-Horta; U Di Mario
Journal:  Diabetologia       Date:  2003-07-29       Impact factor: 10.122

9.  Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial.

Authors:  K Sadeharju; A-M Hämäläinen; M Knip; M Lönnrot; P Koskela; S M Virtanen; J Ilonen; H K Akerblom; H Hyöty
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

10.  Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.

Authors:  M Li; D-J Zheng; L L Field; V Bonnevie-Nielsen
Journal:  Exp Diabetes Res       Date:  2009-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.